Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions
The study examined the prevalence and correlates of substance use disorders and treatment utilization among lifetime MDMA users. Secondary analyses were conducted on data from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey o...
Gespeichert in:
| Veröffentlicht in: | Journal of Drug Issues 2010-07, Vol.40 (3), p.537-551 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 551 |
|---|---|
| container_issue | 3 |
| container_start_page | 537 |
| container_title | Journal of Drug Issues |
| container_volume | 40 |
| creator | Niv, Noosha Warda, Umme S. Grella, Christine E. Moore, Alison A. Sarkisyan, Diana Karno, Mitchell P. |
| description | The study examined the prevalence and correlates of substance use disorders and treatment utilization among lifetime MDMA users. Secondary analyses were conducted on data from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey of adults in the United States. Lifetime MDMA use was assessed, and MDMA users (n = 562) were compared to a matched sample of non-MDMA users. Substance use diagnoses were made using the AUDADIS – DSM-IV, and data on treatment utilization were collected. MDMA use was significantly related to lifetime and past-year substance use disorders as well as treatment utilization in bivariate analyses. Multivariate analysis, however, showed that MDMA use was not related to lifetime substance use diagnosis or to treatment utilization. MDMA use still had the strongest association with past-year substance use disorders. Screening for substance use disorders and nicotine dependence may be warranted among adults who report lifetime MDMA use to help identify treatment needs and provide proper referrals. |
| doi_str_mv | 10.1177/002204261004000301 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3816501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_002204261004000301</sage_id><sourcerecordid>835114533</sourcerecordid><originalsourceid>FETCH-LOGICAL-c533t-df135c3889d7bd3940ac082643a86d86431555ada42eb4e3426b787e1cc7bfaf3</originalsourceid><addsrcrecordid>eNqNkk1v1DAQhi0EokvhD3BAFhdOoXZsJw4HpNW2fEgtSG33HDn2ZNeVEy-2U6n8Dn4wTreULwlxmsM87zvzjgah55S8prSujwgpS8LLihLCCSGM0AdoQRsuCsqq5iFazEAxEwfoSYxXmaE1EY_RQclpIzlrFujbxdTFpEYNeB0BH9vog4EQsRoNvgyg0gBjwutknf2qkvUjVoMfN_js-Gw5S0J8g88hTi5F3Ac_4LQF_OmWVA6f7KyBwXrnN1bjiylcww3OHkun_da72ynn4FQCg1d-NHbWxafoUa9chGd39RCt351crj4Up5_ff1wtTwstGEuF6SkTmknZmLozrOFEaSLLijMlKyNzpUIIZRQvoePA8iG6WtZAta67XvXsEL3d--6mbgCjc9KgXLsLdlDhpvXKtr93RrttN_66ZZJWgtBs8OrOIPgvE8TUDjZqcE6N4KfYSiYo5XnZ_yPLpiGZfPkHeeWnkI-ZIVpVdc4825V7SAcfY4D-fmlK2vk52r-fI4te_Br3XvLjGzJwtAei2sDPsf-w_A6O7cOC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>816671353</pqid></control><display><type>article</type><title>Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions</title><source>Access via SAGE</source><source>Sociological Abstracts</source><creator>Niv, Noosha ; Warda, Umme S. ; Grella, Christine E. ; Moore, Alison A. ; Sarkisyan, Diana ; Karno, Mitchell P.</creator><creatorcontrib>Niv, Noosha ; Warda, Umme S. ; Grella, Christine E. ; Moore, Alison A. ; Sarkisyan, Diana ; Karno, Mitchell P.</creatorcontrib><description>The study examined the prevalence and correlates of substance use disorders and treatment utilization among lifetime MDMA users. Secondary analyses were conducted on data from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey of adults in the United States. Lifetime MDMA use was assessed, and MDMA users (n = 562) were compared to a matched sample of non-MDMA users. Substance use diagnoses were made using the AUDADIS – DSM-IV, and data on treatment utilization were collected. MDMA use was significantly related to lifetime and past-year substance use disorders as well as treatment utilization in bivariate analyses. Multivariate analysis, however, showed that MDMA use was not related to lifetime substance use diagnosis or to treatment utilization. MDMA use still had the strongest association with past-year substance use disorders. Screening for substance use disorders and nicotine dependence may be warranted among adults who report lifetime MDMA use to help identify treatment needs and provide proper referrals.</description><identifier>ISSN: 0022-0426</identifier><identifier>EISSN: 1945-1369</identifier><identifier>DOI: 10.1177/002204261004000301</identifier><identifier>PMID: 24198439</identifier><identifier>CODEN: JDGIA6</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Drug abuse ; Ecstasy ; Substance Abuse ; Substance abuse treatment ; Surveys ; Tests ; United States of America</subject><ispartof>Journal of Drug Issues, 2010-07, Vol.40 (3), p.537-551</ispartof><rights>2010 Florida State University College of Criminology and Criminal Justice</rights><rights>Copyright Florida State University for and on behalf of The Florida State University Board of Trustees Summer 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c533t-df135c3889d7bd3940ac082643a86d86431555ada42eb4e3426b787e1cc7bfaf3</citedby><cites>FETCH-LOGICAL-c533t-df135c3889d7bd3940ac082643a86d86431555ada42eb4e3426b787e1cc7bfaf3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/002204261004000301$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/002204261004000301$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>230,313,314,780,784,792,885,21819,27344,27922,27924,27925,33774,33775,43621,43622</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24198439$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niv, Noosha</creatorcontrib><creatorcontrib>Warda, Umme S.</creatorcontrib><creatorcontrib>Grella, Christine E.</creatorcontrib><creatorcontrib>Moore, Alison A.</creatorcontrib><creatorcontrib>Sarkisyan, Diana</creatorcontrib><creatorcontrib>Karno, Mitchell P.</creatorcontrib><title>Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions</title><title>Journal of Drug Issues</title><addtitle>J Drug Issues</addtitle><description>The study examined the prevalence and correlates of substance use disorders and treatment utilization among lifetime MDMA users. Secondary analyses were conducted on data from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey of adults in the United States. Lifetime MDMA use was assessed, and MDMA users (n = 562) were compared to a matched sample of non-MDMA users. Substance use diagnoses were made using the AUDADIS – DSM-IV, and data on treatment utilization were collected. MDMA use was significantly related to lifetime and past-year substance use disorders as well as treatment utilization in bivariate analyses. Multivariate analysis, however, showed that MDMA use was not related to lifetime substance use diagnosis or to treatment utilization. MDMA use still had the strongest association with past-year substance use disorders. Screening for substance use disorders and nicotine dependence may be warranted among adults who report lifetime MDMA use to help identify treatment needs and provide proper referrals.</description><subject>Drug abuse</subject><subject>Ecstasy</subject><subject>Substance Abuse</subject><subject>Substance abuse treatment</subject><subject>Surveys</subject><subject>Tests</subject><subject>United States of America</subject><issn>0022-0426</issn><issn>1945-1369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>BHHNA</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNqNkk1v1DAQhi0EokvhD3BAFhdOoXZsJw4HpNW2fEgtSG33HDn2ZNeVEy-2U6n8Dn4wTreULwlxmsM87zvzjgah55S8prSujwgpS8LLihLCCSGM0AdoQRsuCsqq5iFazEAxEwfoSYxXmaE1EY_RQclpIzlrFujbxdTFpEYNeB0BH9vog4EQsRoNvgyg0gBjwutknf2qkvUjVoMfN_js-Gw5S0J8g88hTi5F3Ac_4LQF_OmWVA6f7KyBwXrnN1bjiylcww3OHkun_da72ynn4FQCg1d-NHbWxafoUa9chGd39RCt351crj4Up5_ff1wtTwstGEuF6SkTmknZmLozrOFEaSLLijMlKyNzpUIIZRQvoePA8iG6WtZAta67XvXsEL3d--6mbgCjc9KgXLsLdlDhpvXKtr93RrttN_66ZZJWgtBs8OrOIPgvE8TUDjZqcE6N4KfYSiYo5XnZ_yPLpiGZfPkHeeWnkI-ZIVpVdc4825V7SAcfY4D-fmlK2vk52r-fI4te_Br3XvLjGzJwtAei2sDPsf-w_A6O7cOC</recordid><startdate>201007</startdate><enddate>201007</enddate><creator>Niv, Noosha</creator><creator>Warda, Umme S.</creator><creator>Grella, Christine E.</creator><creator>Moore, Alison A.</creator><creator>Sarkisyan, Diana</creator><creator>Karno, Mitchell P.</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7U3</scope><scope>7U4</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>88I</scope><scope>88J</scope><scope>8AF</scope><scope>8AM</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BGRYB</scope><scope>BHHNA</scope><scope>CCPQU</scope><scope>DWI</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>HEHIP</scope><scope>K7.</scope><scope>K9-</scope><scope>K9.</scope><scope>M0O</scope><scope>M0R</scope><scope>M0S</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M2R</scope><scope>M2S</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>WZK</scope><scope>5PM</scope></search><sort><creationdate>201007</creationdate><title>Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions</title><author>Niv, Noosha ; Warda, Umme S. ; Grella, Christine E. ; Moore, Alison A. ; Sarkisyan, Diana ; Karno, Mitchell P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c533t-df135c3889d7bd3940ac082643a86d86431555ada42eb4e3426b787e1cc7bfaf3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Drug abuse</topic><topic>Ecstasy</topic><topic>Substance Abuse</topic><topic>Substance abuse treatment</topic><topic>Surveys</topic><topic>Tests</topic><topic>United States of America</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niv, Noosha</creatorcontrib><creatorcontrib>Warda, Umme S.</creatorcontrib><creatorcontrib>Grella, Christine E.</creatorcontrib><creatorcontrib>Moore, Alison A.</creatorcontrib><creatorcontrib>Sarkisyan, Diana</creatorcontrib><creatorcontrib>Karno, Mitchell P.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Social Services Abstracts</collection><collection>Sociological Abstracts (pre-2017)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Criminal Justice Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Criminology Collection</collection><collection>Sociological Abstracts</collection><collection>ProQuest One Community College</collection><collection>Sociological Abstracts</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Sociology Collection</collection><collection>ProQuest Criminal Justice (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Criminal Justice Database</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Sociological Abstracts (Ovid)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of Drug Issues</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niv, Noosha</au><au>Warda, Umme S.</au><au>Grella, Christine E.</au><au>Moore, Alison A.</au><au>Sarkisyan, Diana</au><au>Karno, Mitchell P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions</atitle><jtitle>Journal of Drug Issues</jtitle><addtitle>J Drug Issues</addtitle><date>2010-07</date><risdate>2010</risdate><volume>40</volume><issue>3</issue><spage>537</spage><epage>551</epage><pages>537-551</pages><issn>0022-0426</issn><eissn>1945-1369</eissn><coden>JDGIA6</coden><abstract>The study examined the prevalence and correlates of substance use disorders and treatment utilization among lifetime MDMA users. Secondary analyses were conducted on data from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), a nationally representative survey of adults in the United States. Lifetime MDMA use was assessed, and MDMA users (n = 562) were compared to a matched sample of non-MDMA users. Substance use diagnoses were made using the AUDADIS – DSM-IV, and data on treatment utilization were collected. MDMA use was significantly related to lifetime and past-year substance use disorders as well as treatment utilization in bivariate analyses. Multivariate analysis, however, showed that MDMA use was not related to lifetime substance use diagnosis or to treatment utilization. MDMA use still had the strongest association with past-year substance use disorders. Screening for substance use disorders and nicotine dependence may be warranted among adults who report lifetime MDMA use to help identify treatment needs and provide proper referrals.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>24198439</pmid><doi>10.1177/002204261004000301</doi><tpages>15</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-0426 |
| ispartof | Journal of Drug Issues, 2010-07, Vol.40 (3), p.537-551 |
| issn | 0022-0426 1945-1369 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3816501 |
| source | Access via SAGE; Sociological Abstracts |
| subjects | Drug abuse Ecstasy Substance Abuse Substance abuse treatment Surveys Tests United States of America |
| title | Substance Use Disorders and Treatment Utilization among MDMA Users: Results from the National Epidemiologic Survey on Alcohol and Related Conditions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T22%3A05%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substance%20Use%20Disorders%20and%20Treatment%20Utilization%20among%20MDMA%20Users:%20Results%20from%20the%20National%20Epidemiologic%20Survey%20on%20Alcohol%20and%20Related%20Conditions&rft.jtitle=Journal%20of%20Drug%20Issues&rft.au=Niv,%20Noosha&rft.date=2010-07&rft.volume=40&rft.issue=3&rft.spage=537&rft.epage=551&rft.pages=537-551&rft.issn=0022-0426&rft.eissn=1945-1369&rft.coden=JDGIA6&rft_id=info:doi/10.1177/002204261004000301&rft_dat=%3Cproquest_pubme%3E835114533%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=816671353&rft_id=info:pmid/24198439&rft_sage_id=10.1177_002204261004000301&rfr_iscdi=true |